Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC

NCT: NCT07596134 · NOT_YET_RECRUITING

NCT IDNCT07596134
StatusNOT_YET_RECRUITING
Start Date2026-10-15
Completion2029-10-15
SponsorZhejiang University (OTHER)
First posted
Last updated

Brief Summary

Multimodal Thermal Therapy combined with targeted therapy and immunotherapy versus targeted therapy and immunotherapy alone for systemically untreated unresectable hepatocellular carcinoma (HCC)

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑